Allergan and Perrigo announced the Food and Drug Administration (FDA) approval for generic equivalents to Reckitt Benckiser’s Mucinex DM Regular and Maximum Strengths and Mucinex Maximum Strength: Guaifenesin 600mg and Dextromethorphan 30mg; Guaifenesin 1200mg and Dextromethorphan 60mg; and Guaifenesin 1200mg tablets.

Mucinex Maximum Strength is an expectorant indicated for relief of chest congestion and to thin and loosen mucus. Mucinex DM Regular and Maximum Strengths are expectorants indicated to control cough and also thin mucus.

RELATED: Less Sleep May Up Risk of Catching a Cold

Perrigo will begin shipment of the products in time for the 2016 cough and cold season.

For more information visit or